Figure 1.
Treatment pathways across lines of therapy. ASC, asciminib; BOS, bosutinib, DAS, dasatinib; IMA, imatinib; NIL, nilotinib; PON, ponatinib; TFR, treatment-free remission.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.